Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 1
2006 2
2007 3
2008 4
2009 3
2010 2
2011 3
2012 2
2013 6
2015 2
2016 4
2017 1
2018 2
2019 2
2020 1
2021 2
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Exenatide in acute ischemic stroke.
Daly SC, Chemmanam T, Loh PS, Gilligan A, Dear AE, Simpson RW, Bladin CF. Daly SC, et al. Among authors: dear ae. Int J Stroke. 2013 Oct;8(7):E44. doi: 10.1111/ijs.12073. Int J Stroke. 2013. PMID: 24024920 Clinical Trial. No abstract available.
Advances in Design and Development of Lumi-Solve: A Novel Drug-Eluting Photo-Angioplasty Device.
Sangeetha Menon A, Subasic de Azevedo I, Choong K, Bhatnagar D, Wang C, Sluka P, Chisholm DR, Pasic P, Thissen H, Sama G, Robinson A, Rodda A, Tria A, Spiegel L, Dharma A, Kaipananickal H, Okabe J, El-Osta A, Mountford S, Thompson P, Dear AE. Sangeetha Menon A, et al. Among authors: dear ae. Cardiovasc Eng Technol. 2023 Aug;14(4):605-614. doi: 10.1007/s13239-023-00668-0. Epub 2023 May 10. Cardiovasc Eng Technol. 2023. PMID: 37165253 Free PMC article.
Incretin based therapeutics: connections to vascular biology and implications for potential cardiovascular disease prevention: Editorial to: "Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa B activation" by Dai et al.
Dear AE. Dear AE. Cardiovasc Drugs Ther. 2013 Oct;27(5):363-4. doi: 10.1007/s10557-013-6465-x. Cardiovasc Drugs Ther. 2013. PMID: 23722420 No abstract available.
A pilot clinical study to Evaluate Liraglutide-mediated Anti-platelet activity in patients with type-2 Diabetes (ELAID study).
Loganathan J, Cohen AC, Kaloupis GM, Harris C, Chronopoulos A, James V, Hamilton J, Green S, Wallis A, Morgan S, Dauer R, Gilfillan C, Dear AE. Loganathan J, et al. Among authors: dear ae. J Diabetes Complications. 2022 May;36(5):108188. doi: 10.1016/j.jdiacomp.2022.108188. Epub 2022 Mar 30. J Diabetes Complications. 2022. PMID: 35382966 Clinical Trial.
38 results